You are here:

telavancin hydrochloride (Vibativ)

Advice

in the absence of a submission from the holder of the marketing authorisation

telavancin hydrochloride (Vibativ®) is not recommended for use within NHS Scotland.

Indication under review: treatment of adults with nosocomial pneumonia (NP) including ventilator associated pneumonia, known or suspected to be caused by methicillin-resistant Staphylococcus aureus (MRSA).

The holder of the marketing authorisation has not made a submission to SMC regarding this product in this indication.  As a result we cannot recommend its use within NHSScotland.

Drug Details

Drug Name: telavancin hydrochloride (Vibativ)
SMC Drug ID: 1015/14
Manufacturer: Clinigen Healthcare Ltd
Indication: Treatment of adults with nosocomial pneumonia (NP) including ventilator associated pneumonia, known or suspected to be caused by methicillin-resistant Staphylococcus aureus (MRSA).
BNF Category:
Submission Type: Non submission
Status: Not Recommended
Date Advice Published: 10 November 2014

Back